Veeva Systems Expands Its Collaboration with Roche Pharmaceuticals to Enhance Customer Engagement

Veeva Systems and Roche Pharmaceuticals: A Partnership Built on Innovation

In a significant development that showcases the ongoing collaboration between two giants in the healthcare and technology sectors, Veeva Systems, a leader in the life sciences cloud software market, recently announced the expansion of its partnership with Roche Pharmaceuticals. This strategic alliance aims to leverage advanced technologies to enhance customer engagement through personalized interactions.

What’s New in the Partnership?

On November 24, 2025, Veeva Systems revealed that Roche has opted to implement the Veeva Vault CRM across its global pharmaceutical organization. This decision marks a pivotal moment in their long-standing relationship. As Veeva CEO Peter Gassner stated, the company feels honored to extend their partnership, emphasizing the commitment to deliver next-generation AI-enabled customer relationship management (CRM) solutions. The new collaboration is expected to empower Roche’s field teams with insightful tools tailored to meet the needs of healthcare professionals and the patients they serve.

Why Vault CRM?

The Vault CRM is more than just a software solution; it embodies a comprehensive suite of applications designed for commercial execution in the life sciences sector. With a strong foundation on data-driven insights, Vault CRM aims to create tailored interactions, ultimately fostering better connections between healthcare providers and pharmaceutical representatives. Roche’s Chief Digital and Technology Officer, Wafaa Mamilli, expressed excitement over the expansion of this partnership, highlighting how data and AI will play crucial roles in creating personalized customer engagements.

One of the most notable advancements is the integration of Veeva AI, which utilizes agentic AI principles within the Vault platform. This includes specialized AI-driven agents like the Free Text Agent, Voice Agent, Pre-call Agent, and Media Agent, all set to launch by December 2025. These innovations signal Veeva's commitment to enhancing the sales and communication strategies for its partners.

Impact on the Pharmaceutical Industry

The pharmaceutical landscape is constantly evolving, and the integration of advanced technologies is essential for staying ahead. By adopting the latest CRM solutions, Roche aims to not only enhance its operational efficiency but also deepen relationships with healthcare professionals. In an industry that emphasizes personalization and rapid adaptation, leveraging AI for customer engagement presents a significant competitive advantage.

Furthermore, Veeva's approach as a Public Benefit Corporation underlines its commitment to not just its shareholders but also to stakeholders at large, including customers and employees. This balanced focus is critical in a time when corporate responsibility and innovation go hand in hand.

The Future of Healthcare Customer Engagement

This partnership extension signals a broader trend within the healthcare sector, whereby organizations are increasingly turning to tech innovations to drive engagement and operational success. As Veeva continues to roll out its AI enhancements, the implications for Pharma teams are vast – they will have access to tools that not only improve efficiency but also foster more meaningful connections with healthcare providers and patients.

Roche's move to implement the Vault CRM demonstrates a significant shift towards harnessing technology for better health outcomes. As both companies embark on this new chapter of their collaboration, the healthcare industry watches closely to see how these advancements will translate into improved patient care and enhanced operational capabilities.

For more information about Veeva’s products and services, visit veeva.com.